Myeloproliferative Syndrome - A Diagnosis on the Border Between Medical Specialties
References
- Zinzani P.L. The many faces of marginal zone lymphoma. ASH Educ Progr B. 2012;2012(1):426–432.
- Lenglet J., Traullé C., Mounier N., Benet C., Munoz-Bongrand N., Amorin S. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment. Leuk Lymphoma. 2013;55:1854–1860.
- Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H. In: World Health Organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al., editors. International Agency for Research on Cancer (IARC); Lyon: 2008. International Agency for Research on Cancer (IARC). 422 p.
- Behdad A., Bailey N.G. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings. Arch Pathol Lab Med. 2014;138(10): 1295–1301.
- Traverse-Glehen A., Baseggio L., Salles G., Felman P., Berger F. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification. Curr Opin Oncol. 2011;23(5):441–448.
- Matutes E., Oscier D., Montalban C., Berger F., Callet-Bauchu E., Dogan A. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia. 2008;22(3):487–495.
- Moreau E.J., Matutes E., A'Hern R.P., Morilla A.M., Morilla R.M., Owusu-Ankomah K.A. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8(CD79b) Am J Clin Pathol. 1997;108(4):378–382.
- Chacón J.I., Mollejo M., Muñoz E., Algara P., Mateo M., Lopez L. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood. 2002;100(5):1648–1654.
- Iannitto E., Ambrosetti A., Ammatuna E., Colosio M., Florena A.M., Tripodo C. Splenic marginal zone lymphoma with or without villous lymphocytes. Cancer. 2004;101(9):2050–2057.
- Kalpadakis C., Pangalis G.A., Vassilakopoulos T.P., Sachanas S., Angelopoulou M.K. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned? Leuk Lymphoma. 2014;55(7):1463–1470.
- Arcaini L., Rossi D., Paulli M. Splenic marginal zone lymphoma: from genetics to management. Blood. 2016;127(17):2072–2081.
- Tsimberidou A.M., Catovsky D., Schlette E., O'Brien S., Wierda W.G., Kantarjian H. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer. 2006;107(1):125–135.
- Thieblemont C., Felman P., Berger F., Dumontet C., Arnaud P., Hequet O. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma. 2002;3(1):41–47.
- Kalpadakis C., Pangalis G.A., Maria K.A., Sachanas S., Kontopidou F.N., Yiakoumis X. Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy. Oncologist. 2013;18(2):190–197.
- Else M., Marín-Niebla A., de la Cruz F., Batty P., Ríos E., Dearden C.E. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma. Br J Haematol. 2012;159(3):322–328.
- Kalpadakis C., Pangalis G.A., Dimopoulou M.N., Vassila-kopoulos T.P., Kyrtsonis M-C., Korkolopoulou P. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematol Oncol. 2007;25(3): 127–131.
- Bennett M., Yegena S., Chubar E., Schechter G. Rituximab monotherapy in splenic marginal zone lymphoma instead of splenectomy. Br J Haematol. 2010;149(Suppl. 1):45.
- Dreyling M., Thieblemont C., Gallamini A., Arcaini L., Campo E., Hermine O. Esmo consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol. 2013;24(4):857–877.
Language: English
Page range: 81 - 96
Published on: Apr 15, 2023
Published by: Romanian Society of Internal Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2023 Marilena Stoian, Andrei Turbatu, Bianca Procopiescu, Silviu Șeitan, Gabriel Scarlat, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.